Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 513.26 USD -0.55% Market Closed
Market Cap: 196.3B USD
Have any thoughts about
Thermo Fisher Scientific Inc?
Write Note

Wall Street
Price Targets

TMO Price Targets Summary
Thermo Fisher Scientific Inc

Wall Street analysts forecast TMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMO is 667.52 USD with a low forecast of 591.05 USD and a high forecast of 805.35 USD.

Lowest
Price Target
591.05 USD
15% Upside
Average
Price Target
667.52 USD
30% Upside
Highest
Price Target
805.35 USD
57% Upside

TMO Last Price Targets
Thermo Fisher Scientific Inc

The latest public price target was made on Oct 24, 2024 by Catherine Schulte from Robert W. Baird , who expects TMO stock to rise by 21% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Catherine Schulte
Robert W. Baird
622 USD
Upside 21%
4 weeks ago
Oct 24, 2024
Thermo Fisher Scientific (TMO) PT Lowered to $622 at Baird
StreetInsider
Luke Sergott
Barclays
610 USD
Upside 19%
1 month ago
Oct 23, 2024
Thermo Fisher price target lowered to $610 from $620 at Barclays
TheFly
Vijay Kumar
Evercore ISI
630 USD
Upside 23%
1 month ago
Oct 1, 2024
Thermo Fisher price target raised to $630 from $605 at Evercore ISI
TheFly
Daniel Arias
Stifel Nicolaus
680 USD
Upside 32%
2 months ago
Sep 20, 2024
Thermo Fisher Scientific (TMO) PT Raised to $680 at Stifel
StreetInsider
Catherine Schulte
Robert W. Baird
632 USD
Upside 23%
2 months ago
Sep 20, 2024
Baird Reiterates Outperform Rating on Thermo Fisher Scientific (TMO)
StreetInsider
Patrick Donnelly
Citigroup
620 USD
Upside 21%
2 months ago
Sep 19, 2024
Citi Reiterates Neutral Rating on Thermo Fisher Scientific (TMO)
StreetInsider
Justin Bowers
Deutsche Bank
630 USD
Upside 23%
2 months ago
Sep 18, 2024
Thermo Fisher Scientific (TMO) PT Raised to $630 at Deutsche Bank
StreetInsider
Derik de Bruin
Bank of America Securities
675 USD
Upside 32%
2 months ago
Sep 16, 2024
Thermo Fisher Scientific (TMO) PT Raised to $675 at BofA Securities
StreetInsider
Andrew Cooper
Raymond James
660 USD
Upside 29%
3 months ago
Jul 25, 2024
Thermo Fisher price target raised to $660 from $650 at Raymond James
TheFly
Luke Sergott
Barclays
600 USD
Upside 17%
4 months ago
Jun 28, 2024
Thermo Fisher price target lowered to $600 from $615 at Barclays
TheFly
Sidharth Sahoo
HSBC
670 USD
Upside 31%
6 months ago
Apr 30, 2024
Thermo Fisher price target raised to $670 from $660 at HSBC
TheFly
Luke Sergott
Barclays
615 USD
Upside 20%
6 months ago
Apr 25, 2024
Thermo Fisher price target raised to $615 from $590 at Barclays
TheFly
Justin Bowers
Deutsche Bank
610 USD
Upside 19%
6 months ago
Apr 25, 2024
Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank
StreetInsider
Catherine Schulte
Robert W. Baird
670 USD
Upside 31%
10 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Andrew Cooper
Raymond James
530 USD
Upside 3%
1 year ago
Oct 26, 2023
These Analysts Lower Their Forecasts On Thermo Fisher After Q3 Results
Benzinga
Thermo Fisher
Credit Suisse
620 USD
Upside 21%
1 year ago
Jul 13, 2023
Credit Suisse Upgrades Thermo Fisher, Calls It Best-Of-Breed Asset
Benzinga
Unknown Analyst
Cowen & Co.
711 USD
Upside 39%
1 year ago
Feb 2, 2023
Cowen & Co. Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $711
Benzinga
Unknown Analyst
Leerink Partners
630 USD
Upside 23%
1 year ago
Feb 2, 2023
SVB Leerink Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $630
Benzinga
Unknown Analyst
Barclays
660 USD
Upside 29%
1 year ago
Feb 2, 2023
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $660
Benzinga
Unknown Analyst
Citigroup
700 USD
Upside 36%
1 year ago
Feb 2, 2023
Citigroup Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $700
Benzinga
Show More Price Targets
Show Less Price Targets
Catherine Schulte
Robert W. Baird
Price Target 622 USD
Upside/Downside 21%
View Source
Luke Sergott
Barclays
Price Target 610 USD
Upside/Downside 19%
View Source
Vijay Kumar
Evercore ISI
Price Target 630 USD
Upside/Downside 23%
View Source
Daniel Arias
Stifel Nicolaus
Price Target 680 USD
Upside/Downside 32%
View Source
Catherine Schulte
Robert W. Baird
Price Target 632 USD
Upside/Downside 23%
View Source
Patrick Donnelly
Citigroup
Price Target 620 USD
Upside/Downside 21%
View Source
Justin Bowers
Deutsche Bank
Price Target 630 USD
Upside/Downside 23%
View Source
Derik de Bruin
Bank of America Securities
Price Target 675 USD
Upside/Downside 32%
View Source
Andrew Cooper
Raymond James
Price Target 660 USD
Upside/Downside 29%
View Source
Luke Sergott
Barclays
Price Target 600 USD
Upside/Downside 17%
View Source
Sidharth Sahoo
HSBC
Price Target 670 USD
Upside/Downside 31%
View Source
Luke Sergott
Barclays
Price Target 615 USD
Upside/Downside 20%
View Source
Justin Bowers
Deutsche Bank
Price Target 610 USD
Upside/Downside 19%
View Source
Catherine Schulte
Robert W. Baird
Price Target 670 USD
Upside/Downside 31%
View Source
Andrew Cooper
Raymond James
Price Target 530 USD
Upside/Downside 3%
View Source
Thermo Fisher
Credit Suisse
Price Target 620 USD
Upside/Downside 21%
View Source
Unknown Analyst
Cowen & Co.
Price Target 711 USD
Upside/Downside 39%
View Source
Unknown Analyst
Leerink Partners
Price Target 630 USD
Upside/Downside 23%
View Source
Unknown Analyst
Barclays
Price Target 660 USD
Upside/Downside 29%
View Source
Unknown Analyst
Citigroup
Price Target 700 USD
Upside/Downside 36%
View Source
Show More Price Targets
Show Less Price Targets
Thermo Fisher Scientific Inc Competitors:
Price Targets
SEER
Seer Inc
26% Upside
ICLR
ICON PLC
36% Upside
ONT
Oxford Nanopore Technologies PLC
45% Upside
WST
West Pharmaceutical Services Inc
15% Upside
A
Agilent Technologies Inc
13% Upside
RVU
Ryvu Therapeutics SA
81% Upside
DHR
Danaher Corp
25% Upside
EVT
Evotec SE
52% Upside

Revenue
Forecast

Revenue Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 12%. The projected CAGR for the next 3 years is 4%.

12%
Past Growth
4%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-30%
Average Miss

Net Income
Forecast

Net Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-28%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TMO's stock price target?
Price Target
667.52 USD

According to Wall Street analysts, the average 1-year price target for TMO is 667.52 USD with a low forecast of 591.05 USD and a high forecast of 805.35 USD.

What is Thermo Fisher Scientific Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 12%. The projected CAGR for the next 3 years is 4%.

What is Thermo Fisher Scientific Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

What is Thermo Fisher Scientific Inc's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 19%.

Back to Top